Open AccessIt is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies
Author(s) -
Caroline Besson
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.279457
Subject(s) - covid-19 , vaccination , medicine , virology , administration (probate law) , immunology , political science , infectious disease (medical specialty) , disease , outbreak , law
Not available.